iOS app Android app


Icahn, ImClone Turn Down Bristol-Myers Offer

DealBook | Posted 05.25.2011 | Business

ImClone Systems, the maker of the anti-cancer drug Erbitux, said on Monday that while it is studying a $4.5 billion takeover bid from Bristol-Myers Sq...

Drug Improves Survival Rate Of Late-Stage Lung Cancer Patients

CNNMoney | Posted 05.25.2011 | Business

ImClone Systems Inc. and Bristol-Myers Squibb Co. said Tuesday the drug Erbitux improved the survival rate of lung cancer patients in a late-stage stu...